Search

Your search keyword '"Blessin, Niclas C."' showing total 158 results

Search Constraints

Start Over You searched for: Author "Blessin, Niclas C." Remove constraint Author: "Blessin, Niclas C."
158 results on '"Blessin, Niclas C."'

Search Results

1. PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors

2. Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder

3. Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer

4. TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities

5. Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid

6. Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder

7. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors

8. Nonredundant Upregulation of CD112R (PVRIG) and PD-1 on Cytotoxic T Lymphocytes Located in T Cell Nests of Colorectal Cancer

9. GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder

10. Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence

11. Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer

12. Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers

13. Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder.

14. CEA (CEACAM5) expression is common in muscle‐invasive urothelial carcinoma of the bladder but unrelated to the disease course

16. Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

17. Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry

18. Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors

19. Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder

20. Data from BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration

21. Supplementary Figures 1 - 12, Supplementary Tables 1-5 from BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration

22. BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration

23. Abstract 3436: Reduced p63 expression is linked to a low density of regulatory T-cells and unfavorable prognosis in muscle-invasive urothelial carcinoma of the bladder

24. Abstract 6649: Prevalence and spatial interplay of mononuclear phagocyte and lymphocyte subpopulations in 49 carcinoma entities in respect to its TIM3, PD-1, PD-L1 and CTLA-4 expression using BLEACH&STAIN

25. Abstract 5438: The combination of artificial intelligence and BLEACH&STAIN multiplex fluorescence immunohistochemistry facilitates automated prostate and breast cancer detection

26. Abstract 5144: Spatial T-cell atlas in more than 100 different tumor entities using BLEACH&STAIN

27. Automated Ki ‐67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry

28. PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples

29. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors

30. Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma

31. T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer

37. Abstract P069: Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence

38. Abstract P068: Automated cell type specific PD-L1 quantification by artificial intelligence using high throughput bleach & stain 15-marker multiplex fluorescence immunohistochemistry in human cancers

39. Transcriptome Analysis in Vulvar Squamous Cell Cancer

40. High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer

41. Prevalence of proliferating CD8+ cells in normal lymphatic tissues, inflammation and cancer

42. Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors

43. High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma

44. Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

45. High RSF1 protein expression is an independent prognostic feature in prostate cancer

46. Abstract 4104: Expression of the immune checkpoint receptor TIGIT in seminoma

47. Abstract 4567: Distribution of CD8+cytotoxic lymphocytes in human neoplasms

48. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

49. Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers.

50. Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

Catalog

Books, media, physical & digital resources